Comparison of Uterine Repair Methods for Cesarean Delivery

December 14, 2018 updated by: Valerie Zaphiratos, Maisonneuve-Rosemont Hospital

Randomized Controlled Trial of Uterine Exteriorization Versus in Situ Repair for Elective Cesarean Delivery

This study is designed to compare the exteriorization of the uterus versus the in situ repair for closure of the hysterotomy incision with a completely standardized anesthetic protocol.

Study Overview

Detailed Description

Two well-known uterine repair techniques are described; the uterus can be repaired in situ within the peritoneal cavity (intraabdominal) or exteriorized temporarily from the abdomen for the closure of the hysterotomy incision (extraabdominal). 3 meta-analysis on the topic were unable to demonstrate the superiority of one technique regarding maternal morbidities. However, there is a paucity of studies with a standardized anesthetic protocol evaluating these outcomes.

This study will evaluate the impact of the uterine repair technique on different maternal morbidities; focusing on intra-operative nausea and vomiting under a standardized anesthetic protocol.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H1T 2M4
        • Maisonneuve-Rosemont Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Elective cesarean delivery
  • Term gestation, 37 weeks or more
  • Healthy parturients (ASA 1 and 2)
  • Spinal anesthesia

Exclusion Criteria:

  • Conditions at risk of uterine atony and/or postpartum hemorrhage (multiple gestation, placenta accrete / previa, pre-eclampsia / eclampsia, uterine leiomyomata, polyhydramnios)
  • Morbid obesity (BMI > 35 kg / m2) at delivery
  • Coagulopathy
  • Active labor
  • Cardiomyopathy
  • Emergency cesarean section
  • Refusal/Inability to consent
  • Language other than English or French

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: In situ uterine repair
The uterus is repaired in situ within the abdominal cavity, without exteriorization; intra-abdominal repair
The uterine incision is closed with the uterus within the abdominal cavity
Other Names:
  • Intra-abdominal uterine repair
Active Comparator: Exteriorization of the uterus
The uterine incision is repaired with the exteriorization of the uterus; extra-abdominal repair
The uterine incision is repaired with the exteriorization of the uterus
Other Names:
  • Extra-abdominal uterine repair
  • Exteriorisation of the uterus

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of intraoperative nausea and vomiting
Time Frame: Intraoperative

Incidence of intraoperative nausea and vomiting using a scale of 0 to 3; 0 being no nausea, 1 being light nausea, 2 being severe nausea, and 3 being nausea accompanied with vomiting and / or retching.

The patients will be questioned at 5 pre-determined time points during the cesarean delivery.

Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypotension
Time Frame: Intraoperative
Hypotensive episodes, defined as a difference of more than 20% of the baseline mean arterial pressure, despite a phenylephrine infusion
Intraoperative
Pelvic irrigation
Time Frame: Intraoperative
To determine if the patient had pelvic irrigation, yes or no
Intraoperative
Length of surgery
Time Frame: Intraoperative
Intraoperative
Estimated blood loss
Time Frame: Intraoperative
Measuring suction canisters and wet sponges
Intraoperative
Reduction in hemoglobin
Time Frame: Within 24 hours of surgery
Difference between preoperative and postoperative hemoglobin within 24 hours of surgery
Within 24 hours of surgery
Incidence of endometritis
Time Frame: Through study completion; on average of 1 year
Through study completion; on average of 1 year
Time to return of bowel function
Time Frame: Up to 2 weeks
The return of bowel function will be assessed by listening to each of the four abdominal quadrants for intestinal peristalsis with a stethoscope twice a day and by assessing the time of the first gas or bowel movement. The first occurrence of any of these events will determine the return of intestinal transit.
Up to 2 weeks
Length of hospital stay after the cesarean delivery
Time Frame: Through study completion on average of 1 year
Through study completion on average of 1 year
Incidence of tachycardia
Time Frame: Intraoperative
Tachycardia, defined as a heart rate above 100 beats per minute
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

July 1, 2018

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

October 21, 2015

First Submitted That Met QC Criteria

October 23, 2015

First Posted (Estimate)

October 27, 2015

Study Record Updates

Last Update Posted (Actual)

December 17, 2018

Last Update Submitted That Met QC Criteria

December 14, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 151019

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complications; Cesarean Section

Clinical Trials on Type A of uterine repair: In situ

Subscribe